Drugmaker Lupin on Friday said it has received approval from the US health regulator to market Droxidopa capsules, used to treat dizziness. The company has received approval from the US Food and Drug Administration (USFDA) for Droxidopa capsules in strengths of 100 mg, 200 mg, and 300 mg.
